Breast cancer is one of the most clear-cut examples of a solid tumor in which systemic cues play a decisive part in its development. The breast tissue is constantly subjected to changes in hormone levels and modifications in the microenvironment. This scenario is even more striking during tumor development because of the dramatic loss or aberration of basement membrane (BM) and myoepithelial cells and the gain of peritumoral myofibroblasts. We suggest that the microenvironment, defined here as all components of the mammary gland other than luminal and/or tumor epithelial cells, might be instrumental in maintaining organ integrity and in promoting, and at times even initiating, breast cancer development. As such, the tumor microenvironment and its constituents, alone or in combination, might serve as promising targets for therapy.
Breast cancer and stroma: for better or worseTumor development is a prolonged and circuitous process and, similar to what has been postulated for normal organ homeostasis [1], should be regarded as a continuous reciprocal interaction between tumor cells and their surrounding microenvironment [2], in which stromal cells and the extracellular matrix (ECM) have decisive roles. The other cell types and the ECM constituents that surround the tumors are different from those that are contained in normal tissue (reviewed in [3]). In the normal breast, the luminal epithelial microenvironment includes myoepithelial cells, basement membrane (BM) and the collective complex referred to as 'stroma' (fibroblasts, vasculature, immune cells and interstitial ECM). In invasive breast cancer, myoepithelial cells and BM are essentially lost, and tumor cells are in direct contact with a remodeled interstitial stroma comprising fibroblasts and myofibroblasts, tumor vasculature and a considerable number of infiltrating immune cells, such as lymphocytes, macrophages and mast cells. Although several of the molecular mechanisms underlying the emergence of the individual cellular phenotypes have now been elucidated, the full potential of the tumor microenvironment as a possible target for diagnosis, prognosis and therapy has yet to be appreciated, understood and applied.Until recently, the acceptance of a microenvironmental contribution to tumor development was limited mostly to that of a role for angiogenesis in solid tumors beyond a certain size [4]. The more recent, albeit broad, focus on the importance of the microenvironment, in particular inflammation, in essence represents a renaissance of the historic view of cancer as a never-